Latest Production News

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.

Tesoro Gold has reported a significant 42% increase in its Ternera gold resource alongside a robust scoping study and a $34 million equity raise to accelerate development of its El Zorro project in Chile.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Arovella Therapeutics has secured encouraging feedback from the US FDA on reagent testing for its CAR-iNKT cell therapy, setting the stage for an IND filing this quarter and clinical trials in early 2026.

NOVONIX has reached mutual agreement to draw down an additional US$40 million tranche of convertible debentures from Yorkville Advisors, advancing its funding strategy to support growth in battery technology.

Big River Industries reports a 4.9% sales decline year-to-date but highlights stabilizing revenue and resilient margins, with a cautious outlook on residential recovery and steady commercial demand.

BetMakers Technology Group kicks off FY26 with a strong financial turnaround and strategic advances, including a promising acquisition and digital wagering expansion in Nevada.

Astral Resources has strengthened its leadership and advisory teams to drive the Mandilla Gold Project towards production, targeting first gold output by the end of 2027. The company has also engaged GR Engineering Services for critical feasibility work and appointed Taylor Collison to assist with debt financing.

Focus Minerals reported a record gold pour in August 2025 and steady production at its Coolgardie Gold Project, supported by operational efficiencies and exploration progress.

Big River Industries faced a tough FY2025 with subdued residential demand but showed resilience through cost control and cash generation. The company declared a modest dividend and announced key board changes as it eyes recovery.

BetMakers Technology Group has reported a remarkable 361% growth in adjusted EBITDA for Q1 FY26, driven by strong revenue gains and operational efficiencies, while advancing its strategic expansion into the Las Vegas racing market.

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.